SVFC -- there are two trading in NYSE trading @ 4-10/ share range and all have no significant revenue and multimillion in losses. That said SVFC, which has patent and has been proven effective in research, will follow the norm. We are at the bottom and will very soon explosively climb to the level of other biotechs IMO
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.